The ownership structure of Molecular Partners (MOLN) stock is a mix of institutional, retail and individual investors. Approximately 2.34% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 97.66% is owned by Public Companies and Individual Investors.
The ownership structure of Molecular Partners (MOLN) stock is a mix of institutional, retail and individual investors. Approximately 2.34% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 97.66% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder
# of Shares
Type
% Holding
Value
1,070
Institution
<0.01%
5,179
Top Mutual Fund Holders
Holder
# of Shares
Type
% Holding
Value
1,070
Institution
<0.01%
5,179
Top ETF Holders
Holder
# of Shares
Type
% Holding
Value
FAQ
Who Owns Molecular Partners (MOLN)?
According to the latest TipRanks data, approximately 2.33% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 97.66% is held by retail investors.
What percentage of Molecular Partners (MOLN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.33% of Molecular Partners (MOLN) stock is held by institutional investors.
What percentage of Molecular Partners (MOLN) stock is held by retail investors?
According to the latest TipRanks data, approximately 97.66% of Molecular Partners (MOLN) stock is held by retail investors.
Who owns the most shares of Molecular Partners (MOLN)?
Fidelity Concord Street Trust owns the most shares of Molecular Partners (MOLN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.